Juan Pablo Frias, MD, lists scores on 3 common screening tests (fasting plasma glucose, hemoglobin A1C, and 75g oral glucose tolerance) that indicates someone in an intermediary position between normal...
Tricia Santos Cavaiola, MD, discusses why inhaled insulin, although effective and possibly preferable to injected insulin therapy, has a questionable future.
Tricia Santos Cavaiola, MD, discussses concentrated insulin and its role as an important tool for managing severe insulin resistance in type-2 diabetes cases.
Juan Pablo Frias, MD, discusses an FDA-approved medication option that will help reduce blood sugar levels in conjunction with diet and exercise in patients with type 2 diabetes.
Ralph Rogers, MD, PhD, MBA, discusses the intersection of wearable health-monitoring devices and telemedicine platforms and how they might lead to better management of chronic diseases like diabetes,...
In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr. MD, and Hope Warshaw, RD, CDE, BC-ADM, about the multidisciplinary approach to managing patients with diabetes and...
In one of the first clinical trials intended to compare the standard of care for diabetic foot wounds against EpiFix, a dehydrated human amnion/chorion membrane allograft (dHACM), researchers found...
This video details a study of how patients with type 2 diabetes who also have liver cirrhosis associated with hepatitis C virus infection fare when treated with metformin.
Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...
